HIGHLIGHTS
- who: Yasmin M. Ahmed and collaborators from the Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Riyadh, Saudi Arabia have published the paper: Partial Synthetic PPAR Derivative Ameliorates Aorta Injury in Experimental Diabetic Rats Mediated by Activation of miR-126-5p Pi3k/AKT/PDK 1/mTOR Expression, in the Journal: Pharmaceuticals 2022, 1175 of /2022/
- what: The authors aimed to experimentally investigate the efficacy of newly designed synthetic PPARu03b1/u03a5 partial agonists on a High-Fat Diet (HFD)/streptozotocin (STZ)-induced T2D. The study designed a new partial synthetic PPARu03a5 ligand derivative to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.